Variant report

Variant	rs374772018
Chromosome Location	chr6:26342572-26342573
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:12)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:26340823..26342973-chr6:26490879..26493737,2	K562	blood:
2	chr6:26338579..26343405-chr6:26519686..26522615,5	K562	blood:
3	chr6:26339036..26342767-chr6:26596200..26598139,3	K562	blood:
4	chr6:26272455..26274796-chr6:26340559..26343243,3	MCF-7	breast:
5	chr6:26340224..26344158-chr6:26569567..26573981,6	K562	blood:
6	chr6:26342125..26345094-chr6:26474079..26475850,2	K562	blood:
7	chr6:26341541..26342734-chr6:26595701..26596713,9	K562	blood:
8	chr6:26341478..26343917-chr6:26362438..26365038,2	K562	blood:
9	chr6:26340127..26342724-chr6:26570668..26572890,2	MCF-7	breast:
10	chr6:26342168..26345048-chr6:26509847..26512007,2	MCF-7	breast:
11	chr6:26342033..26344696-chr6:26521826..26523631,2	MCF-7	breast:
12	chr6:26341150..26343678-chr6:26575652..26577197,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000146109	Chromatin interaction
ENSG00000228223	Chromatin interaction
ENSG00000218690	Chromatin interaction
ENSG00000168242	Chromatin interaction
ENSG00000199289	Chromatin interaction

Extended variants
information (count: 11 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:11 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1029920	chr6:25638507-26585842	Bivalent/Poised TSS Flanking Active TSS ZNF genes & repeats Enhancers Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Active TSS Genic enhancers Strong transcription Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1215 gene(s)	inside rSNPs	diseases
2	nsv538162	chr6:25638507-26585842	Flanking Active TSS Active TSS ZNF genes & repeats Genic enhancers Weak transcription Strong transcription Enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1215 gene(s)	inside rSNPs	diseases
3	nsv1030351	chr6:25813178-26352046	Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	1189 gene(s)	inside rSNPs	diseases
4	nsv1023453	chr6:25853830-26528250	Weak transcription Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	1201 gene(s)	inside rSNPs	diseases
5	nsv428137	chr6:25987413-26351920	Enhancers Flanking Active TSS Active TSS Weak transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	1181 gene(s)	inside rSNPs	diseases
6	nsv1018665	chr6:26026870-26352046	Flanking Active TSS Weak transcription Active TSS Enhancers Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	1116 gene(s)	inside rSNPs	diseases
7	nsv482729	chr6:26291011-26470898	Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	45 gene(s)	inside rSNPs	diseases
8	nsv5230	chr6:26321593-26361531	Weak transcription Bivalent Enhancer Flanking Active TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	32 gene(s)	inside rSNPs	diseases
9	esv3521788	chr6:26334022-26356973	Flanking Active TSS Weak transcription Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
10	esv3521789	chr6:26334022-26356973	Weak transcription Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	17 gene(s)	inside rSNPs	diseases
11	nsv601174	chr6:26341301-26350938	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	8 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:63 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26341400-26343000	Active TSS	HUES64 Cell Line	embryonic stem cell
2	chr6:26341600-26342600	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr6:26341600-26342800	Active TSS	iPS-18 Cell Line	embryonic stem cell
4	chr6:26341600-26342800	Flanking Active TSS	HepG2	liver
5	chr6:26341600-26343000	Active TSS	iPS-15b Cell Line	embryonic stem cell
6	chr6:26341600-26343200	Active TSS	HUES6 Cell Line	embryonic stem cell
7	chr6:26341800-26342600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
8	chr6:26341800-26342600	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
9	chr6:26341800-26342600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr6:26341800-26342800	Active TSS	H9 Cell Line	embryonic stem cell
11	chr6:26341800-26342800	Enhancers	Muscle Satellite Cultured Cells	--
12	chr6:26341800-26342800	Flanking Active TSS	Dnd41	blood
13	chr6:26341800-26343000	Active TSS	ES-I3 Cell Line	embryonic stem cell
14	chr6:26341800-26343000	Active TSS	HUES48 Cell Line	embryonic stem cell
15	chr6:26341800-26343000	Active TSS	iPS-20b Cell Line	embryonic stem cell
16	chr6:26342000-26342600	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr6:26342000-26342600	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
18	chr6:26342000-26342600	Flanking Active TSS	Primary T cells fromperipheralblood	blood
19	chr6:26342000-26342600	Bivalent/Poised TSS	Brain Germinal Matrix	brain
20	chr6:26342000-26342600	Flanking Active TSS	Hela-S3	cervix
21	chr6:26342000-26342800	Active TSS	H1 Cell Line	embryonic stem cell
22	chr6:26342000-26342800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr6:26342000-26342800	Weak transcription	Right Atrium	heart
24	chr6:26342200-26342600	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
25	chr6:26342200-26342600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr6:26342200-26342600	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr6:26342200-26342600	Enhancers	Primary hematopoietic stem cells short term culture	blood
28	chr6:26342200-26342600	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
29	chr6:26342200-26342600	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
30	chr6:26342200-26342600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr6:26342200-26342600	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
32	chr6:26342200-26342600	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr6:26342200-26342600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
34	chr6:26342200-26342600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
35	chr6:26342200-26342600	Flanking Bivalent TSS/Enh	Fetal Kidney	kidney
36	chr6:26342200-26342600	Enhancers	Placenta Amnion	Placenta Amnion
37	chr6:26342200-26342600	Active TSS	Rectal Mucosa Donor 29	rectum
38	chr6:26342200-26342600	Flanking Active TSS	GM12878-XiMat	blood
39	chr6:26342200-26342600	Enhancers	HUVEC	blood vessel
40	chr6:26342200-26342600	Flanking Active TSS	K562	blood
41	chr6:26342200-26342600	Flanking Active TSS	NH-A	brain
42	chr6:26342200-26342600	Flanking Active TSS	NHDF-Ad	bronchial
43	chr6:26342200-26342600	Flanking Active TSS	NHLF	lung
44	chr6:26342200-26342600	Flanking Active TSS	Osteobl	bone
45	chr6:26342200-26342800	Active TSS	ES-WA7 Cell Line	embryonic stem cell
46	chr6:26342200-26342800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr6:26342200-26342800	Enhancers	HMEC	breast
48	chr6:26342200-26343600	Enhancers	NHEK	skin
49	chr6:26342400-26342600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
50	chr6:26342400-26342600	Enhancers	Primary T helper naive cells from peripheral blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links